Tag : Veterinary Drug Directorate of Health Canada

Current News Health

Canopy Growth Corp. to Conduct Clinical Trials Using CBD to Treat Anxiety in Animals

Editor
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Canopy Health Innovations Inc. has announced this morning that they been approved by the Veterinary Drug Directorate of Health Canada to research the effectiveness of the non-psychoactive cannabinoid cannabidiol (“CBD”) to treat anxiety in pets. Numerous studies has been released...